FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/10/075322 [Registered on: 15/10/2024] Trial Registered Prospectively
Last Modified On: 07/10/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A clinical study to know the benefit of Prabhakar vati and Sarpagandha vati in shonita dusti with reference to essential hypertension 
Scientific Title of Study   A comparative clinical to evaluate the efficacy of prabhakara vati with sarpagandha vati in shonita dusti with special reference to essential hypertension  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Jyoti Ashok Belavi 
Designation  PG Scholar 
Affiliation  Shri Shivayoogeeshwar Rural Ayurvedic College Hospital Inchal  
Address  Shri Shivayoogeeshwar Rural Ayurvedic College and Hospital Inchal -591102 kayachikitsa department Tq-Savadatti Dist-Belagavi
Shri Shivayoogeeshwar Rural Ayurvedic College and Hospital Inchal
Belgaum
KARNATAKA
591102
India 
Phone  8073224705  
Fax    
Email  belavijyoti@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Jyoti Ashok Belavi 
Designation  PG Scholar 
Affiliation  Shri Shivayoogeeshwar Rural Ayurvedic College Hospital Inchal  
Address  Shri Shivayoogeeshwar Rural Ayurvedic College and Hospital Inchal Kaya chikitsa department Tq-Savadatti Dist-Belagavi
Shri Shivayoogeeshwar Rural Ayurvedic College and Hospital Inchal
Belgaum
KARNATAKA
591102
India 
Phone  8073224705  
Fax    
Email  belavijyoti@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Jyoti Ashok Belavi 
Designation  PG Scholar 
Affiliation  Shri Shivayoogeeshwar Rural Ayurvedic College Hospital Inchal  
Address  Shri Shivayoogeeshwar Rural Ayurvedic College and Hospital Inchal Kaya chikitsa department Tq-Savadatti Dist-Belagavi
Shri Shivayoogeeshwar Rural Ayurvedic College and Hospital Inchal -591102 kayachikitsa department Tq-Savadatti Dist-Belagavi
Belgaum
KARNATAKA
591102
India 
Phone  8073224705  
Fax    
Email  belavijyoti@gmail.com  
 
Source of Monetary or Material Support  
Shri Shivayogeeshwar Rural Ayurvedic College and Hospital Inchal 
 
Primary Sponsor  
Name  Jyoti Ashok Belavi 
Address  SSRAMC Inchal 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Jyoti  Dr. Jyoti  Shri Shivayoogeeshwar Rural Ayurvedic College and Hospital Inchal -591102 kayachikitsa department Tq-Savadatti Dist-Belagavi
Belgaum
KARNATAKA 
8073224705

belavijyoti@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Clearance Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:I00-I99||Diseases of the circulatory system. Ayurveda Condition: RADITA/RUDITA-DASHTAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Prabhakar vati, Reference: Govindadas. Bhaisajya Ratnavali. Shri Lalchandra vaidya editor. Varanasi- Chaukhambha orientalia.sloka .Pp820, p438., Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 250(mg), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 21 Days, anupAna/sahapAna: Yes(details: ushna jala), Additional Information: -
2Comparator ArmDrugClassical(1) Medicine Name: sarpanaganda vati, Reference: Yadavji trikamji acharya.Siddhayoga sangraha.11 edition.Shri baidhyanartha Ayurveda bhavan limited Naini.2003.chapter-19. Pp164,p101, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 250(mg), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 21 Days, anupAna/sahapAna: Yes(details: Usher jala), Additional Information: -
 
Inclusion Criteria  
Age From  30.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patients presenting with samanya lakshana of Shonita dusti. 
 
ExclusionCriteria 
Details  Patients with history of cerebrovascular accident, chronic kidney disease. diabetic mellitus
other systemic,Metabolic disorders.
Patients having secondary hypertension.
Patients with history of Disorders related with haemopoietic system like Leukemia
Hemophilia
Unconscious, Coma patient, and Patients who are suffering with Gastro-intestinal
bleeding disorders. 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Headache reduced  After 14 days 
 
Secondary Outcome  
Outcome  TimePoints 
Improved in generalised weakness and daily activities   After 21 days of treatment 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   20/10/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="0"
Days="21" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

The samanya chikitsa of Shonita dusti is Raktapittahara kriya, Virechana, Upavasaa and Rakta sravana . In that Raktapittahara kriya plays vital role in planning the treatment,which mainly aimed as Vyadhipratyanika and Samprapti vighatana Chikitsa.

On classical literature analysis the main siddhanta of chikitsa is Samprapti vighatana of the disease. Prabhakar vati is one such drug which is mentioned in Hrudrogadhikar of Bhaishajya Ratnavali. Its constituents helps to do Samprapti vighatana of Shonita dusti and also helps to prevent further complications caused by Essential hypertension, as it contains swarnamakshika bhasma, Loha bhasma, Abhraka bhasma, Vamshalochana, Shilajatu and Arjuna kwath as bhavana dravya

. It is having Madhura, Tikta rasa, Sheeta veerya and overall karmukata is Pitta Shamana with Tridosha hara properties. Thus does the Shamana of Vyadhis caused by Shonita dusti . Hence Prabhakra vati is choosen for the current study.Sarpagandha vati is explained under Brama-Anidra-Unmad adhikar of Siddhayoga sangraha and it contains Sarpagandha, Jatamansi, Parasika Yavani, Pippalimoola, Bhanga.Sarpagandha vati is having predominantly having Tikta rasa and act as Raktashodhaka. It is nidrajanak and a nutrient for brain, which can be used to relieve anxiety, stress and mental fatigue 

 
Close